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Introductionz Staphylococcus aurelts is one of the important human pathogens, that can
cause many infections, such as endocarditis and osteomyelitis. Aminoglycosides are broad-
spectrum antibiotics that are often used in combination with other antibiotics for the
treatment of severe S. aureus infections. The typing based on polymorphism of the coagulase
gene (coa) is a simple, accurate, reproducible and commonly used to study the epidemiology
of S. aureus strains. The main purpose of the study is the phenotypic and genotypic
evaluation of aminoglycoside resistance and molecular analysis of the coagulase gene in
clinical isolates of S. aureus in Kerman, Iran.
Materialandmethods:During oneyearperiod,atotalof 130 S.aureus isolateswere
collected from inpatients and outpatients. All isolates were tested by disk diffusion method
for susceptibility to 13 antibiotics and MIC of gentamicin and amikacin were evaluated by
micro broth dilution method. The frequency of mecA and AME genes were determined by
PCR and coa amplification products of all isolates were subjected to restriction analysis using
the enzyme HaeIII.
Results: Among, total 1305. aureus strains isolated, 58(44 o/o) were MRSA. All S.
oureus isolates were susceptible to vancomycin and the highest rates of resistance were
detected for tetracycline (537o), followed by erythromycin (460/o), kanamycin (43o/o) and
gentamicin Q2'A.Among AME genes, aac(6')-Ie-aph(2')-I gene was the most predominant
27(20yo), followed by aph(3')-IIIa 13 (10oA, ant(4)-Ia l3(10YA and aph(2")-Id 4(3.1%A.
PCR amplification of the 3' end region of coa produced 11 different PCR product and
digestion of the PCR products with HaeIII produced 19 distinct RFLP banding pattems.
Conclusion: Given the alarming rate of aminoglycoside resistance among the MRSA
isolates, the monitoring of aminoglycoside resistance and AME genes should be performed to
reduce treatment failure in patients with staphylococcal infections. Coagulase gene typing
and PCR-MLP of the coa gene provide simple, inexpensive and efficient results for
epidemiological investigations during nosocomial outbreaks.
Keywords: Staphylococcus aureus, Aminoglycoside resistance, Aminoglycoside
modifuing enzymes, Coagulase typing
